CCN2 and cancer: Both MMP7 and CCN2 have been associated with poor prognosis in different types of cancer (Klupp et al, 2016; Sun et al, 2017) and with fibrotic or inflammatory diseases (Dendooven et al, 2011; Irvine et al, 2016).